Howard Becker
About Howard Becker
Howard Becker is a Speciality Account Executive at Bristol-Myers Squibb with over 30 years of experience in the pharmaceutical industry.
Title at Bristol-Myers Squibb
Howard Becker currently holds the position of Speciality Account Executive at Bristol-Myers Squibb. In this role, he focuses on the commercialization and strategic placement of specialty pharmaceutical products, ensuring they meet market needs and gain necessary formulary access.
Education and Expertise in Pharmacy
Howard Becker attended the University of the Sciences in Philadelphia, where he studied Pharmacy. He obtained a B.S. Pharmacy degree, completing his studies from 1971 to 1976. This educational background laid the foundation for his extensive career in the pharmaceutical industry.
Decades of Experience in Pharmaceutical Industry
With over 30 years of experience in the pharmaceutical industry, Howard Becker brings a wealth of knowledge to his role. His tenure has given him deep insights into both specialty and mainstream pharmaceutical products, as well as market dynamics and regulatory environments.
Market Access and Managed Care Expertise
In the past 15 years, Howard Becker has specialized in market access and managed care sectors. His role involved interfacing with key regional health plans to influence medical policy and secure pharmacy formulary access, ensuring that products meet payer and patient needs effectively.
Experience with Specialty Pharmacy Providers
Howard Becker has worked extensively with Specialty Pharmacy Providers (SPPs). His experience includes navigating the complexities of specialty pharmaceuticals and ensuring that these products are made available to patients through appropriate channels.
Sales and Account Management Skills
Throughout his career, Howard Becker has demonstrated capabilities in executive sales, sales management, marketing, account management, and training. His diverse skill set has been pivotal in building and maintaining excellent customer relationships and achieving business goals in the pharmaceutical sector.